We provide end-to-end support, acting as your dedicated partner or seamlessly integrating with your existing teams and preferred vendors.
1. Strategic Clinical Development & Regulatory Planning:
- Early-Phase Strategy & Integrated Development: We specialize in crafting agile and efficient clinical development plans, particularly for early-phase (Phase I/II) studies common in rare diseases, ensuring alignment with your overall product development strategy and target product profile (TPP).
- Regulatory Roadmapping: Our clinical strategies are interwoven with global regulatory insights, supporting Investigational New Drug (IND), Clinical Trial Application (CTA), and other crucial regulatory submissions from the outset.
- Feasibility & Risk Assessment: Comprehensive analysis to identify potential challenges early and develop mitigation strategies for study startup and execution.
2. Expert Clinical Trial Design & Biostatistics:
- Innovative Trial Methodologies: We champion the use of innovative and adaptive trial designs suited for small populations, including N-of-1 trials, basket/umbrella/platform trials, and Bayesian approaches, to maximize data generation and efficiency.
- Robust Biostatistical Expertise: Our in-house team of expert biostatisticians provides critical support from concept to close-out, including:
- Sophisticated sample size calculations and power analyses.
- Development of robust Statistical Analysis Plans (SAPs).
- Data modeling, simulation, and advanced statistical analysis.
- Endpoint Selection & Validation: Guidance on selecting and validating clinically meaningful primary and secondary endpoints, including the development and integration of Patient-Reported Outcomes (PROs), Clinician-Reported Outcomes (ClinROs), and Observer-Reported Outcomes (ObsROs), as well as leveraging novel biomarkers.
3. Full-Service Clinical Trial Management & Execution:
- Dedicated Project Management: Experienced project managers ensure meticulous oversight, adherence to timelines, budget management, and transparent communication.
- Site Identification, Qualification & Activation: Leveraging our networks and expertise to identify, qualify, select, and efficiently activate appropriate investigator sites globally, with a focus on centers of excellence for specific rare diseases.
- Patient Recruitment & Retention: Developing and implementing tailored strategies to effectively recruit and retain patients in rare disease trials, often involving close collaboration with patient advocacy groups (PAGs) and utilizing digital outreach.
- Clinical Monitoring: Comprehensive site monitoring (on-site, remote, and risk-based) to ensure patient safety, data integrity, and GCP compliance.
- Data Management & EDC Solutions: End-to-end data management services, including eCRF design, EDC system deployment (compliant with 21 CFR Part 11), data cleaning, query resolution, and adherence to CDISC standards (SDTM, ADaM).
- Pharmacovigilance & Safety Monitoring: Rigorous safety surveillance, adverse event reporting, and coordination with Data Safety Monitoring Boards (DSMBs).
- Compliance & Quality Assurance: Unwavering commitment to ICH-GCP guidelines, applicable global regulatory requirements, and internal quality standards.
4. CRO & Vendor Management/Partnership:
- Functioning as Your Dedicated CRO: We can take full responsibility for the operational execution of your clinical trial, offering a single point of accountability.
- Collaborative CRO & Vendor Oversight: If you have existing CRO or vendor relationships, or require specialized niche providers, we offer expert oversight services. This includes:
- Vendor selection and qualification.
- Performance management and milestone tracking.
- Ensuring alignment with your strategic objectives and quality standards.
- Gap analysis and issue resolution.
5. CMO Coordination & Clinical Supply Chain Management:
- Seamless CMO Liaison: We act as a crucial link with your Contract Manufacturing Organizations (CMOs) to ensure timely production, quality control, packaging, labeling (including multi-language and country-specific requirements), and release of clinical trial materials (CTM).
- GMP-Compliant CTM: Verifying that all CTM is manufactured and handled according to Good Manufacturing Practices (GMP).
- Global Logistics & Distribution: Managing the complex logistics of CTM distribution to clinical sites worldwide, including cold-chain management for temperature-sensitive biologics, cell and gene therapies, and other advanced modalities.
- Import/Export & Depot Management: Navigating international trade compliance for clinical supplies and coordinating with global depots.
6. Medical Writing & Regulatory Submission Support:
- High-Quality Clinical Documentation: Preparation of key clinical documents, including:
- Clinical study protocols and amendments.
- Investigator's Brochures (IBs).
- Patient-centric Informed Consent Forms (ICFs).
- Clinical Study Reports (CSRs) compliant with ICH E3.
- Regulatory Document Contribution: Providing expert input and authoring for the clinical sections of regulatory submissions (e.g., INDs, IDEs, NDAs, BLAs, MAAs).
7. Patient Centricity at the Core:
- Integrating the Patient Voice: We actively incorporate patient and caregiver perspectives into trial design and conduct to enhance relevance, reduce burden, and improve engagement.
- Collaboration with Patient Advocacy Groups (PAGs): Building strong partnerships with PAGs for insights, recruitment support, and dissemination of information.
- Decentralized Clinical Trial (DCT) Solutions: Implementing appropriate DCT elements (e.g., remote monitoring, telehealth, home health visits, direct-to-patient CTM shipment) to improve accessibility and convenience for rare disease patients.
- Ethical Considerations & Data Transparency: Upholding the highest ethical standards and supporting initiatives for the appropriate return of individual research results to participants.